IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the t...
FDA Device Recall #Z-1945-2024 — Class II — May 10, 2024
Recall Summary
| Recall Number | Z-1945-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 10, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ion Beam Applications S.A. |
| Location | Ottignies-Louvain-La-Neuve, N/A |
| Product Type | Devices |
| Quantity | 2 units |
Product Description
IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.
Reason for Recall
Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances
Distribution Pattern
Worldwide - US Nationwide distribution in the state of Virginia and the country of India.
Lot / Code Information
UDI: SAT140: (01)05404013814015(11)190507(21)SAT140 SAT136: (01)05404013801138(11)201105(21)SAT136 Serial Numbers: SAT136, SAT140 PTS-11 versions from PTS-11.1 and PTS-12 versions, with C230 accelerator
Other Recalls from Ion Beam Applications S.A.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1497-2026 | Class II | IBA Proton Therapy System - PROTEUS 235 | Feb 3, 2026 |
| Z-2693-2024 | Class II | IBA Proton Therapy System - PROTEUS 235- Design... | Jul 10, 2024 |
| Z-3089-2024 | Class II | IBA Proton Therapy System - PROTEUS 235 Proteus... | Jul 8, 2024 |
| Z-1603-2024 | Class II | IBA Proton Therapy System - PROTEUS 235, PTS-10... | Mar 4, 2024 |
| Z-0295-2024 | Class II | IBA Proton Therapy System - PROTEUS 235. PTS-11... | Sep 18, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.